South and Central AmericaTyphoid Fever Vaccines Market to Grow at a CAGR of 7.7% to reach US$ 24.37 million from 2020 to 2027

South and Central America Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable)and Country

Publication Month: Nov 2020 | Report Code: TIPRE00016298 | No. of Pages: 86 | Category: Pharmaceuticals | Status: Published
Covid

The South and Central America typhoid fever vaccines  market is expected to reach US$ 24.37 million in 2027 from US$ 13.79 million. The market is estimated to grow with a CAGR of 7.7% from 2020-2027.

The growth of the market is driven by the factors such as, prevalence of typhoid in the region, and poor sanitation facilities. However, risks associated with typhoid fever vaccines is likely to have negative impact on the growth of the South and Central America Typhoid Fever Vaccines market in the coming years.

 

Typhoid fever is prevalent among the South and Central America (SCAM)n countries where the sanitation, water treatment and waste management is inefficient. Incidence levels of typhoid fever in Brazil has reduced, however, it is still prevalent in the northern part of Brazil. Also, during the investigation of water quality at Olympic venues in 2016 reported high levels of Salmonella typhi contamination at all locations. In Rio, much of the sewage is left untreated and additionally the human faeces and household garbage runs directly into local rivers and beaches. Thus, the presence of high levels of human sewage, and fecal bacteria, indicates the presence of typhoid bacteria in the Rio waterways. Typhoid spreads through fecal-oral transmission, and is contracted through eating and drinking contaminated food and water putting travelers at risk. Thus, CDC recommends typhoid vaccine for those travelling to Brazil.

Thus, the prevalence of typhoid fever in South and Central America (SCAM) countries is likely to have positive impact on typhoid fever vaccines market during the forecast period.  

 

Furthermore, Latin America is hit by the COVID-19 pandemic and thus has profound humanitarian, economic, and political consequences. South and Central America are among the regions with rising number of reported cases of COVID-19. As per the data of Worldometer, Brazil reported 4,780,317 COVID-19 instances, and Argentina recorded 736,609 counts as of October 06, 2020. Deaths reported in Brazil were 143,010 and in Argentina, the death toll was 16,519. They have responded to the situation by closing borders, ordering quarantines, and imposing a host of restrictions to keep people confined at home. In July 2020, The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group..

 

Rest of South and Central AmericaTyphoid Fever Vaccines  Market  Revenue and Forecast to 2027 (US$ Mn)

Rest of South and Central AmericaTyphoid Fever Vaccines  Market  Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :

South and Central AmericaTyphoid Fever Vaccines – Market Segmentation

 

By Vaccine Type

  •       Live Attenuated Vaccine
  •       Capsular Polysaccharide Vaccines
  •       Conjugate Vaccine
  •       Others

By Route of Administration

  •       Oral
  •       Injectable

By Country

  •       Brazil
  •       Argentina
  •       Rest of South and Central America

Company Profiles

  •     GlaxoSmithKline plc
  •     Shanghai institute of biological products co. ltd.
  •     Sanofi
  •     Pax Vax Inc
  •     BHARAT BIOTECH

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America (SCAM) Typhoid Fever Vaccines Market – By Vaccine Type

1.3.2        South and Central America (SCAM) Typhoid Fever Vaccines Market – By Route of Administration

1.3.3        South and Central America (SCAM) Typhoid Fever Vaccines Market – By Country

2.           South and Central America (SCAM) Typhoid Fever Vaccines Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America (SCAM) Typhoid Fever Vaccines Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South and Central America (SCAM) Typhoid Fever Vaccines Market - South and Central America (SCAM) PEST Analysis

4.3         Expert Opinion

5.           South and Central America (SCAM) Typhoid Fever Vaccines Market Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Prevalence of Typhoid in South and Central America (SCAM) Region

5.2         Key Restraints

5.2.1        Risks Associated with Typhoid Fever Vaccines

5.3         Key Market Opportunities

5.3.1        Growing Healthcare Industry in Middle East

5.4         Future Trend

5.4.1        The Growing Trend of Conjugate Vaccine

5.5         Impact Analysis

6.           Typhoid Fever Vaccines Market – South and Central America (SCAM) Analysis

6.1         South and Central America (SCAM) Typhoid Fever Vaccines Market Revenue Forecasts and Analysis

7.           Typhoid Fever Vaccines Market – By Vaccine Type

7.1         Overview

7.2         Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

7.3         Live Attenuated Vaccine

7.3.1        Overview

7.3.2        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Capsular Polysaccharide Vaccines

7.5.1        Overview

7.5.2        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Conjugate Vaccine

7.6.1        Overview

7.6.2        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

7.7         Others

7.7.1        Overview

7.7.2        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.           Typhoid Fever Vaccines Market Analysis – By Route of Administration

8.1         Overview

8.2         Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

8.2.1        Oral

8.2.1.1          Overview

8.2.2        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

8.3         Injectable

8.3.1        Overview

8.3.2        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

9.           Typhoid Fever Vaccines Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         South & Central America: Typhoid Fever Vaccines Market

9.1.1        Overview

9.1.2        South & Central America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)

9.1.3        South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.4        South & Central America: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.5        South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

9.1.6        Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Brazil: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Brazil: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.7        Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          Argentina: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.7.3          Argentina: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

9.1.8        Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

9.1.8.3          Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Typhoid Fever Vaccines Market

10.1      South and Central America: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Shanghai Institute of Biological Products Co., Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Sanofi

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Paxvax Inc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Bharat Biotech

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      GlaxoSmithKline plc.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 2.             South & Central America: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 3.             Brazil: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Brazil: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 5.             Argentina: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 6.             Argentina: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 7.             Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type– Revenue and Forecast to 2027 (USD Million)

Table 8.             Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)

Table 9.             Glossary of Terms, South and Central America (SCAM) Typhoid Fever Vaccines Market

 

LIST OF FIGURES

Figure 1.           Typhoid Fever Vaccines Market Segmentation

Figure 2.           South and Central America (SCAM) Typhoid Fever Vaccines Market Overview

Figure 3.           Capsular Polysaccharide Vaccines Segment Held Largest Share of Typhoid Fever Vaccines Market

Figure 4.           India Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           South and Central America (SCAM) Typhoid Fever Vaccines Market- Leading Country Markets (US$ Mn)

Figure 6.           South and Central America (SCAM) : PEST Analysis

Figure 7.           Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraints

Figure 8.           South and Central America (SCAM) Typhoid Fever Vaccines Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)

Figure 10.        Live Attenuated Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Conjugate Vaccine: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Others: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)

Figure 15.        Oral: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Injectable: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        South & Central America: Typhoid Fever Vaccines Market, by Key Country – Revenue (2019) (USD Million)

Figure 18.        South & Central America: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)

Figure 19.        South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)

Figure 20.        Brazil: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 21.        Argentina: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

Figure 22.        Rest of SCAM: Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (USD Million)

 

 

 

  1.    GlaxoSmithKline plc
  2.    Shanghai institute of biological products co. ltd.
  3.    Sanofi
  4.    Pax Vax Inc
  5.    BHARAT BIOTECH
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America typhoid fever vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America typhoid fever vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00016298
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing